Form 8-K - Current report:
SEC Accession No. 0001213900-20-035894
Filing Date
2020-11-09
Accepted
2020-11-09 16:10:29
Documents
5
Period of Report
2020-11-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129550-8k_inmunebioinc.htm 8-K 24353
2 SCRIPT FOR EARNINGS CALL HELD ON NOVEMBER 5, 2020 ea129550ex99-1_inmunebio.htm EX-99.1 76541
3 PRESS RELEASE, DATED NOVEMBER 9, 2020 ea129550ex99-2_inmunebio.htm EX-99.2 12594
4 GRAPHIC ex99-1_001.jpg GRAPHIC 39532
5 GRAPHIC ex99-1_002.jpg GRAPHIC 13935
  Complete submission text file 0001213900-20-035894.txt   188482
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201297769
SIC: 2836 Biological Products, (No Diagnostic Substances)